Lineage Cell Therapeutics, Inc. (LCTX) — DEFA14A Filings
All DEFA14A filings from Lineage Cell Therapeutics, Inc.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
-
Lineage Cell Therapeutics Files Proxy Materials
— Apr 29, 2026 Risk: low
Lineage Cell Therapeutics, Inc. filed a DEFA14A on April 29, 2026, related to additional definitive proxy soliciting materials. The filing includes proxy materi -
Lineage Cell Therapeutics Files Proxy Supplement
— Jun 11, 2025 Risk: low
Lineage Cell Therapeutics, Inc. (LCTX) is filing a Definitive Additional Materials document (DEFA14A) on June 11, 2025, supplementing its proxy statement for th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX